In re: opioids litigation

In re: opioids litigation refers to a series of legal cases against pharmaceutical companies accused of contributing to the opioid crisis in the United States. Many companies are charged with misleading marketing, downplaying addiction risks, and improperly promoting prescription opioids. As a result, communities and states seek compensation for the costs of addiction treatment and related public health issues. These lawsuits aim to hold manufacturers accountable and provide funds for recovery efforts, addressing the devastating impact of opioid misuse on individuals and communities across the nation.